-report

Global Novel Drug Delivery Systems Market Size, Status and Forecast 2020-2026

  • Esherpa Code:
  • ES-394960
  • Published On:
  • 20-Mar-20
  • Pages:
  • 130
  • Publisher Id:
  • 7087

Downloads Details

Single User $ 3900
Enterprise License $ 7800

Key Questions Answered

Market Size

Size of the market ?
Market size in the coming five years ?

Geolocation

Biggest contributor to this market ?
Countries to watch.

Key Vendors

Vendors in the market
Growth stratagies they've adpated?

Opportunities

Factors contributing growth of the market ?
Prominent opportunities in the market?

CAGR

Growth forcast foe the next 5 years ?
Fastest-growing segments ?

Challenges

Challenges in the present scenario ?
Factors Impacting market growth

                                                  
This report focuses on the global Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems development in North America, Europe, China, Japan, South Korea and India. The key players covered in this study Amgen Teva Roche UCB(Union Chimique Belge) Celgene Merck Gilead Sciences Sanofi Pfizer Takeda Bausch&Lomb Samyang Biopharmaceuticals Johnson & Johnson TOLMAR Astellas AMAG Pharmaceuticals AbbVie Dr Reddy AstraZeneca Aspen Acrotech Biopharma TWi Pharmaceuticals Market segment by Type, the product can be split into Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein–drug Conjugates Others Market segment by Application, split into Hospitals & Clinic Cancer Treatment Centers Others Market segment by Regions/Countries, this report covers North America Europe China Japan South Korea India The study objectives of this report are: To analyze global Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. To present the Novel Drug Delivery Systems development in North America, Europe, China, Japan, South Korea and India. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Novel Drug Delivery Systems are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
                                                
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Novel Drug Delivery Systems Revenue 1.4 Market Analysis by Type 1.4.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Liposomes 1.4.3 PEGylated Proteins & Polypeptides 1.4.4 Polymer Nanoparticle 1.4.5 Protein–drug Conjugates 1.4.6 Others 1.5 Market by Application 1.5.1 Global Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026 1.5.2 Hospitals & Clinic 1.5.3 Cancer Treatment Centers 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Novel Drug Delivery Systems Market Perspective (2015-2026) 2.2 Novel Drug Delivery Systems Growth Trends by Regions 2.2.1 Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Novel Drug Delivery Systems Historic Market Share by Regions (2015-2020) 2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Novel Drug Delivery Systems Market Growth Strategy 2.3.6 Primary Interviews with Key Novel Drug Delivery Systems Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Novel Drug Delivery Systems Players by Market Size 3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2015-2020) 3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2015-2020) 3.1.3 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Novel Drug Delivery Systems Market Concentration Ratio 3.2.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2019 3.3 Novel Drug Delivery Systems Key Players Head office and Area Served 3.4 Key Players Novel Drug Delivery Systems Product Solution and Service 3.5 Date of Enter into Novel Drug Delivery Systems Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2015-2020) 4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2021-2026) 5 Novel Drug Delivery Systems Breakdown Data by Application (2015-2026) 5.1 Global Novel Drug Delivery Systems Market Size by Application (2015-2020) 5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Novel Drug Delivery Systems Market Size (2015-2020) 6.2 Novel Drug Delivery Systems Key Players in North America (2019-2020) 6.3 North America Novel Drug Delivery Systems Market Size by Type (2015-2020) 6.4 North America Novel Drug Delivery Systems Market Size by Application (2015-2020) 7 Europe 7.1 Europe Novel Drug Delivery Systems Market Size (2015-2020) 7.2 Novel Drug Delivery Systems Key Players in Europe (2019-2020) 7.3 Europe Novel Drug Delivery Systems Market Size by Type (2015-2020) 7.4 Europe Novel Drug Delivery Systems Market Size by Application (2015-2020) 8 China 8.1 China Novel Drug Delivery Systems Market Size (2015-2020) 8.2 Novel Drug Delivery Systems Key Players in China (2019-2020) 8.3 China Novel Drug Delivery Systems Market Size by Type (2015-2020) 8.4 China Novel Drug Delivery Systems Market Size by Application (2015-2020) 9 Japan 9.1 Japan Novel Drug Delivery Systems Market Size (2015-2020) 9.2 Novel Drug Delivery Systems Key Players in Japan (2019-2020) 9.3 Japan Novel Drug Delivery Systems Market Size by Type (2015-2020) 9.4 Japan Novel Drug Delivery Systems Market Size by Application (2015-2020) 10 South Korea 10.1 South Korea Novel Drug Delivery Systems Market Size (2015-2020) 10.2 Novel Drug Delivery Systems Key Players in South Korea (2019-2020) 10.3 South Korea Novel Drug Delivery Systems Market Size by Type (2015-2020) 10.4 South Korea Novel Drug Delivery Systems Market Size by Application (2015-2020) 11 India 11.1 India Novel Drug Delivery Systems Market Size (2015-2020) 11.2 Novel Drug Delivery Systems Key Players in India (2019-2020) 11.3 India Novel Drug Delivery Systems Market Size by Type (2015-2020) 11.4 India Novel Drug Delivery Systems Market Size by Application (2015-2020) 12Key Players Profiles 12.1 Amgen 12.1.1 Amgen Company Details 12.1.2 Amgen Business Overview and Its Total Revenue 12.1.3 Amgen Novel Drug Delivery Systems Introduction 12.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2015-2020)) 12.1.5 Amgen Recent Development 12.2 Teva 12.2.1 Teva Company Details 12.2.2 Teva Business Overview and Its Total Revenue 12.2.3 Teva Novel Drug Delivery Systems Introduction 12.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.2.5 Teva Recent Development 12.3 Roche 12.3.1 Roche Company Details 12.3.2 Roche Business Overview and Its Total Revenue 12.3.3 Roche Novel Drug Delivery Systems Introduction 12.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.3.5 Roche Recent Development 12.4 UCB(Union Chimique Belge) 12.4.1 UCB(Union Chimique Belge) Company Details 12.4.2 UCB(Union Chimique Belge) Business Overview and Its Total Revenue 12.4.3 UCB(Union Chimique Belge) Novel Drug Delivery Systems Introduction 12.4.4 UCB(Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.4.5 UCB(Union Chimique Belge) Recent Development 12.5 Celgene 12.5.1 Celgene Company Details 12.5.2 Celgene Business Overview and Its Total Revenue 12.5.3 Celgene Novel Drug Delivery Systems Introduction 12.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.5.5 Celgene Recent Development 12.6 Merck 12.6.1 Merck Company Details 12.6.2 Merck Business Overview and Its Total Revenue 12.6.3 Merck Novel Drug Delivery Systems Introduction 12.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.6.5 Merck Recent Development 12.7 Gilead Sciences 12.7.1 Gilead Sciences Company Details 12.7.2 Gilead Sciences Business Overview and Its Total Revenue 12.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction 12.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.7.5 Gilead Sciences Recent Development 12.8 Sanofi 12.8.1 Sanofi Company Details 12.8.2 Sanofi Business Overview and Its Total Revenue 12.8.3 Sanofi Novel Drug Delivery Systems Introduction 12.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.8.5 Sanofi Recent Development 12.9 Pfizer 12.9.1 Pfizer Company Details 12.9.2 Pfizer Business Overview and Its Total Revenue 12.9.3 Pfizer Novel Drug Delivery Systems Introduction 12.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.9.5 Pfizer Recent Development 12.10 Takeda 12.10.1 Takeda Company Details 12.10.2 Takeda Business Overview and Its Total Revenue 12.10.3 Takeda Novel Drug Delivery Systems Introduction 12.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2015-2020) 12.10.5 Takeda Recent Development 12.11 Bausch&Lomb 10.11.1 Bausch&Lomb Company Details 10.11.2 Bausch&Lomb Business Overview and Its Total Revenue 10.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction 10.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.11.5 Bausch&Lomb Recent Development 12.12 Samyang Biopharmaceuticals 10.12.1 Samyang Biopharmaceuticals Company Details 10.12.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue 10.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction 10.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.12.5 Samyang Biopharmaceuticals Recent Development 12.13 Johnson & Johnson 10.13.1 Johnson & Johnson Company Details 10.13.2 Johnson & Johnson Business Overview and Its Total Revenue 10.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction 10.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.13.5 Johnson & Johnson Recent Development 12.14 TOLMAR 10.14.1 TOLMAR Company Details 10.14.2 TOLMAR Business Overview and Its Total Revenue 10.14.3 TOLMAR Novel Drug Delivery Systems Introduction 10.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.14.5 TOLMAR Recent Development 12.15 Astellas 10.15.1 Astellas Company Details 10.15.2 Astellas Business Overview and Its Total Revenue 10.15.3 Astellas Novel Drug Delivery Systems Introduction 10.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.15.5 Astellas Recent Development 12.16 AMAG Pharmaceuticals 10.16.1 AMAG Pharmaceuticals Company Details 10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue 10.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction 10.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.16.5 AMAG Pharmaceuticals Recent Development 12.17 AbbVie 10.17.1 AbbVie Company Details 10.17.2 AbbVie Business Overview and Its Total Revenue 10.17.3 AbbVie Novel Drug Delivery Systems Introduction 10.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.17.5 AbbVie Recent Development 12.18 Dr Reddy 10.18.1 Dr Reddy Company Details 10.18.2 Dr Reddy Business Overview and Its Total Revenue 10.18.3 Dr Reddy Novel Drug Delivery Systems Introduction 10.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.18.5 Dr Reddy Recent Development 12.19 AstraZeneca 10.19.1 AstraZeneca Company Details 10.19.2 AstraZeneca Business Overview and Its Total Revenue 10.19.3 AstraZeneca Novel Drug Delivery Systems Introduction 10.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.19.5 AstraZeneca Recent Development 12.20 Aspen 10.20.1 Aspen Company Details 10.20.2 Aspen Business Overview and Its Total Revenue 10.20.3 Aspen Novel Drug Delivery Systems Introduction 10.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.20.5 Aspen Recent Development 12.21 Acrotech Biopharma 10.21.1 Acrotech Biopharma Company Details 10.21.2 Acrotech Biopharma Business Overview and Its Total Revenue 10.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction 10.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.21.5 Acrotech Biopharma Recent Development 12.22 TWi Pharmaceuticals 10.22.1 TWi Pharmaceuticals Company Details 10.22.2 TWi Pharmaceuticals Business Overview and Its Total Revenue 10.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction 10.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) 10.22.5 TWi Pharmaceuticals Recent Development 13Analyst's Viewpoints/Conclusions 14Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Disclaimer 14.3 Author Details
                                                  
List of Tables Table 1. Novel Drug Delivery Systems Key Market Segments Table 2. Key Players Covered: Ranking by Novel Drug Delivery Systems Revenue Table 3. Ranking of Global Top Novel Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Liposomes Table 6. Key Players of PEGylated Proteins & Polypeptides Table 7. Key Players of Polymer Nanoparticle Table 8. Key Players of Protein–drug Conjugates Table 9. Key Players of Others Table 10. Global Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Novel Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Novel Drug Delivery Systems Market Share by Regions (2015-2020) Table 14. Global Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Novel Drug Delivery Systems Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Novel Drug Delivery Systems Market Growth Strategy Table 20. Main Points Interviewed from Key Novel Drug Delivery Systems Players Table 21. Global Novel Drug Delivery Systems Revenue by Players (2015-2020) (Million US$) Table 22. Global Novel Drug Delivery Systems Market Share by Players (2015-2020) Table 23. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems as of 2019) Table 24. Global Novel Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Novel Drug Delivery Systems Product Solution and Service Table 27. Date of Enter into Novel Drug Delivery Systems Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 30. Global Novel Drug Delivery Systems Market Size Share by Type (2015-2020) Table 31. Global Novel Drug Delivery Systems Revenue Market Share by Type (2021-2026) Table 32. Global Novel Drug Delivery Systems Market Size Share by Application (2015-2020) Table 33. Global Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 34. Global Novel Drug Delivery Systems Market Size Share by Application (2021-2026) Table 35. North America Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 36. North America Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 37. North America Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 38. North America Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 39. North America Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 40. North America Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 41. Europe Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 43. Europe Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 44. Europe Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 45. Europe Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 46. Europe Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 47. China Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 48. China Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 49. China Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 50. China Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 51. China Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 52. China Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 53. Japan Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 55. Japan Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 56. Japan Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 57. Japan Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 58. Japan Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 59. South Korea Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 60. South Korea Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 61. South Korea Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 62. South Korea Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 63. South Korea Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 64. South Korea Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 65. India Key Players Novel Drug Delivery Systems Revenue (2019-2020) (Million US$) Table 66. India Key Players Novel Drug Delivery Systems Market Share (2019-2020) Table 67. India Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$) Table 68. India Novel Drug Delivery Systems Market Share by Type (2015-2020) Table 69. India Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$) Table 70. India Novel Drug Delivery Systems Market Share by Application (2015-2020) Table 71. Amgen Company Details Table 72. Amgen Business Overview Table 73. Amgen Product Table 74. Amgen Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 75. Amgen Recent Development Table 76. Teva Company Details Table 77. Teva Business Overview Table 78. Teva Product Table 79. Teva Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 80. Teva Recent Development Table 81. Roche Company Details Table 82. Roche Business Overview Table 83. Roche Product Table 84. Roche Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 85. Roche Recent Development Table 86. UCB(Union Chimique Belge) Company Details Table 87. UCB(Union Chimique Belge) Business Overview Table 88. UCB(Union Chimique Belge) Product Table 89. UCB(Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 90. UCB(Union Chimique Belge) Recent Development Table 91. Celgene Company Details Table 92. Celgene Business Overview Table 93. Celgene Product Table 94. Celgene Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 95. Celgene Recent Development Table 96. Merck Company Details Table 97. Merck Business Overview Table 98. Merck Product Table 99. Merck Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 100. Merck Recent Development Table 101. Gilead Sciences Company Details Table 102. Gilead Sciences Business Overview Table 103. Gilead Sciences Product Table 104. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 105. Gilead Sciences Recent Development Table 106. Sanofi Business Overview Table 107. Sanofi Product Table 108. Sanofi Company Details Table 109. Sanofi Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 110. Sanofi Recent Development Table 111. Pfizer Company Details Table 112. Pfizer Business Overview Table 113. Pfizer Product Table 114. Pfizer Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 115. Pfizer Recent Development Table 116. Takeda Company Details Table 117. Takeda Business Overview Table 118. Takeda Product Table 119. Takeda Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 120. Takeda Recent Development Table 121. Bausch&Lomb Company Details Table 122. Bausch&Lomb Business Overview Table 123. Bausch&Lomb Product Table 124. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 125. Bausch&Lomb Recent Development Table 126. Samyang Biopharmaceuticals Company Details Table 127. Samyang Biopharmaceuticals Business Overview Table 128. Samyang Biopharmaceuticals Product Table 129. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 130. Samyang Biopharmaceuticals Recent Development Table 131. Johnson & Johnson Company Details Table 132. Johnson & Johnson Business Overview Table 133. Johnson & Johnson Product Table 134. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 135. Johnson & Johnson Recent Development Table 136. TOLMAR Company Details Table 137. TOLMAR Business Overview Table 138. TOLMAR Product Table 139. TOLMAR Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 140. TOLMAR Recent Development Table 141. Astellas Company Details Table 142. Astellas Business Overview Table 143. Astellas Product Table 144. Astellas Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 145. Astellas Recent Development Table 146. AMAG Pharmaceuticals Company Details Table 147. AMAG Pharmaceuticals Business Overview Table 148. AMAG Pharmaceuticals Product Table 149. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 150. AMAG Pharmaceuticals Recent Development Table 151. AbbVie Company Details Table 152. AbbVie Business Overview Table 153. AbbVie Product Table 154. AbbVie Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 155. AbbVie Recent Development Table 156. Dr Reddy Company Details Table 157. Dr Reddy Business Overview Table 158. Dr Reddy Product Table 159. Dr Reddy Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 160. Dr Reddy Recent Development Table 161. AstraZeneca Company Details Table 162. AstraZeneca Business Overview Table 163. AstraZeneca Product Table 164. AstraZeneca Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 165. AstraZeneca Recent Development Table 166. Aspen Company Details Table 167. Aspen Business Overview Table 168. Aspen Product Table 169. Aspen Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 170. Aspen Recent Development Table 171. Acrotech Biopharma Company Details Table 172. Acrotech Biopharma Business Overview Table 173. Acrotech Biopharma Product Table 174. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 175. Acrotech Biopharma Recent Development Table 176. TWi Pharmaceuticals Company Details Table 177. TWi Pharmaceuticals Business Overview Table 178. TWi Pharmaceuticals Product Table 179. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2015-2020) (Million US$) Table 180. TWi Pharmaceuticals Recent Development Table 181. Research Programs/Design for This Report Table 182. Key Data Information from Secondary Sources Table 183. Key Data Information from Primary Sources List of Figures Figure 1. Global Novel Drug Delivery Systems Market Share by Type: 2020 VS 2026 Figure 2. Liposomes Features Figure 3. PEGylated Proteins & Polypeptides Features Figure 4. Polymer Nanoparticle Features Figure 5. Protein–drug Conjugates Features Figure 6. Others Features Figure 7. Global Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026 Figure 8. Hospitals & Clinic Case Studies Figure 9. Cancer Treatment Centers Case Studies Figure 10. Others Case Studies Figure 11. Novel Drug Delivery Systems Report Years Considered Figure 12. Global Novel Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2026 Figure 14. Global Novel Drug Delivery Systems Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Novel Drug Delivery Systems Market Share by Players in 2019 Figure 17. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2019 Figure 19. North America Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 23. South Korea Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 27. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 31. UCB(Union Chimique Belge) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. UCB(Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 33. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 35. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 37. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 41. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 43. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 45. Bausch&Lomb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 47. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 49. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 51. TOLMAR Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 53. Astellas Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 55. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 56. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 57. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 58. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 59. Dr Reddy Total Revenue (US$ Million): 2019 Compared with 2018 Figure 60. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 61. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 62. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 63. Aspen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 64. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2015-2020) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

What Set Us Apart

Research Analyst
Support

Rest assured that with vetted publishers, you will get the best quality output

Best Buying
Experience

Rest assured that with vetted publishers, you will get the best quality output

Unmatched
Expertise

Rest assured that with vetted publishers, you will get the best quality output

Assured
Quality

Rest assured that with vetted publishers, you will get the best quality output

Widest Report
Option

Rest assured that with vetted publishers, you will get the best quality output

Customer
Centric

Rest assured that with vetted publishers, you will get the best quality output